NCT07825376Not yet recruiting
Branching Scenario-Based Education in Coronary Artery Disease
The Effect of Branching Scenario-Based Education Delivered Through Virtual Reality and Tablet on Cardiovascular Disease Risk Awareness and Antiplatelet Medication Adherence in Patients With Coronary Artery Disease: A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 17 Sept 2026
Brief summary (registry, in English)
This randomized controlled trial aims to evaluate the effects of nurse-led branching scenario-based education delivered through virtual reality and tablet on cardiovascular disease risk awareness and adherence to antiplatelet medication in patients with coronary artery disease. Participants will be randomly assigned to a virtual reality education group, a tablet-based education group, or a control group receiving routine hospital education. Cardiovascular disease risk awareness and medication adherence will be assessed before and after the educational intervention and during follow-up.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 54 (estimated)
- First submitted
- 18 Aug 2026
- Start date
- 1 Sept 2026
- Primary completion date
- Dec 2026
- Lead sponsor
- Abant Izzet Baysal University
- Diseases
- Coronary artery disease
- NCT number
- NCT07825376
What you commit to
- Study type: Interventional
- Planned participants: 54
- From 1 Sept 2026 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Hospitalization within the previous 3 months due to acute myocardial infarction, stroke, or another serious cardiovascular event.
Other illness
- Cognitive impairment or mental illness preventing communication.
- Visual or hearing impairment preventing participation in the virtual reality education.
- Diagnosis of malignant disease.
- Bleeding disorder or active bleeding risk.
Other
- Participation in another clinical study at the same time.
- Unable to understand the educational materials.
- Refusal to provide written informed consent.
Who the study is looking for
- Aged 18-65 years.
- Diagnosed with coronary artery disease.
- Newly initiated on antiplatelet therapy.
- Conscious and able to communicate.
- Physically and cognitively able to use a virtual reality headset.
- Able to read, write, and understand Turkish.
- Willing to provide written informed consent.
- Willing to participate in the education and follow-up process.
- Has not previously received education about coronary artery disease.
- Able to use a smartphone.
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Bolu Abant Izzet Baysal University Coordinator of this site? Confirm its status | Bolu | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.